Our News
We are excited to share our lates news and developments.
June 2025 - London Tech Week
In June we were scouting for latest trends in application of AI in MedTech in the UK's biggest tech forum. AstraZeneca was prominantly represented, as well as number of startups in this field. AI helps to analyze vast volumes of data, research latest trends and scentific findings, drive efficience in lab work and hypothesis testing.
May 2025 - Biotin and Gut Microbiota
New review article by collaborating aspiring scientist soon to be published on Biotin and gut microbiota. Biotin (Vitamin B7) is crucial for cellular metabolism, yet humans cannot synthesize it, relying on diet and gut microbial production. With increasing interest in personalized microbiome analysis, identifying vitamin-producing bacteria is gaining prominence. New review systematically examines existing scientific literature on biotin biosynthesis and the specific contributions of the gut microbiome. New findings move beyond hypothetical links to demonstrate the concrete impact of gut bacteria on host biotin levels. By clarifying the mechanisms and significance of microbial biotin production, this article seeks to bolster confidence of professionals in the microbiome's role in nutrient provision.
April 2025 - Tim Spector and Royal Society of Medicine
In April, allDNA team attended talk with Tim Spector, Professor of Genetic Epidemiology at King’s College London, his research has significantly advanced understanding of the gut microbiome’s role in health, longevity, and disease prevention. Spector is also the scientific co-founder of ZOE, a personalized nutrition company, he advocates for plant-based, high-fiber diets to enhance gut health and challenges conventional nutrition advice. At Royal Society of Medicine event Mr. Spector offered expertise on new methods of sequencing of gut microbiota, explored myths and misconceptions of modern nutrition, provided useful advice to young scientists.
February 2025 - Healthcare Innovators at LIHE
In February, we attended “Scaling Up MedTech and HealthTech Ventures”, hosted by Harvard Business School Alumni Angels at the London Institute for Healthcare Engineering, part of King’s College London. Insights from leading MedTech innovators, including Proximie and Hypervision Surgical, illuminated UK regulatory challenges, while guidance from Amadeus Capital and Truffle Capital proved instrumental in shaping our strategies for scaling and securing funding. The event underscored King’s College’s commitment to translating academic research into practical solutions, advancing healthcare and lifestyle management.
January 2025 - Partnering with King's College talents
We are excited to partner with talented future scientists from King's College London. Together we are looking deeper into systemising latest research on Biotin, as part of human microbiome understanding. Using latest technological advances in Artificial Intelligence, aspiring scientists are helping us to identify relevant research, understand trends and succession with previous 20 years of studies.
December 2024 - Looking deeper into Biotin
Vitamin B7 (more often referred to as Biotin) is a water-soluble B vitamin, that has an important role in cellular metabolism, participating in various processes including fatty acid synthesis, amino acid metabolism, and gluconeogenesis. Humans cannot synthesise B vitamins, including Vitamin B7 (biotin), however it can not only be obtained through dietary uptake, but also produced by gut bacteria. Recent recognition of the significance of the gut microbiome has led to a growing interest in personalized microbiome analysis, allowing individuals to gain better understanding of their gut health, with identification of vitamin-producing bacterial species (including biotin-producing bacteria) and the impact of those on individuals’ health. Upcoming article highlights findings from existing scientific literature on biotin biosynthesis, microbial contributions, and the role of microbiome testing in detecting biotin-producing bacteria. Understanding the gut microbiome’s role in biotin metabolism could lead to novel approaches in personalized nutrition and bring on lifestyle changes. This is an abstract of upcoming article to be published in H1 2025.
November 2024 - First customers signed!
We are excited to start collboration with our first customers (under NDA). Developing state-of-the-art interpretation service for microbiome testing is rewarding and allDNA met the challenge with tight deadlines and customisation required.